TriSalus Life Sciences Warrant
TLSIW
27 hedge funds and large institutions have $6.13M invested in TriSalus Life Sciences Warrant in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
4% more funds holding
Funds holding: 26 → 27 (+1)
0% more capital invested
Capital invested by funds: $6.11M → $6.13M (+$22.1K)
Top Buyers
Top Sellers
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$37K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$4.66K |
| 3 |
Jane Street
New York
|
-$730 |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$334 |
TLSIW Hedge Fund Activity: Q2 2021 in Review
27 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q2 2021, worth a combined $6.13M — up 0.36% from $6.11M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new TLSIW positions and 1 closed out — a net gain of 2 holders — while 8 added to existing stakes and 4 trimmed.
The largest buyer was Vestcor Inc, adding an estimated $76.9K. The largest seller was Polar Asset Management Partners, cutting an estimated $37K.
- 27 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q2 2021, up from 26 in Q1 2021.
- Funds reported $6.13M of TriSalus Life Sciences Warrant stock for Q2 2021, up 0.36% quarter-over-quarter.
- 3 funds opened new TriSalus Life Sciences Warrant positions in Q2 2021 and 1 closed out, a net change of +2 holders.
- The largest TriSalus Life Sciences Warrant buyer in Q2 2021 was Vestcor Inc, an estimated $76.9K added.
- The largest TriSalus Life Sciences Warrant seller in Q2 2021 was Polar Asset Management Partners, an estimated $37K sold.
Based on aggregated 13F filings for Q2 2021.